Heptares Co-Founder Resigns as VP and CSO of Parent Company Sosei Post author:Sam Post published:January 18, 2018 Post category:BioPharma Dr. Marshall will leave Sosei at the end of February 2018. Source: BioSpace You Might Also Like Millendo Therapeutics Sweeps Up Phase II Asset With Acquisition of Small Biotech December 19, 2017 Consolidation Could Be Coming to Pharma Industry March 14, 2018 Senator Harris Scrutinizes How Alkermes Pushed Its Opioid Addiction Drug November 6, 2017
